Table of Contents
PPT Slide
PPT Slide
PPT Slide
CY2001 Achievements
Advanced Drug Delivery vs. Drug Discovery
Advanced Drug Delivery
Risk/Reward Profile
Combining Drug Delivery and Biotechnology
PPT Slide
Overcoming Delivery Barriers to Commercialization
Carrier Selection Process (Cluster analysis for a protein product)
Carrier Optimization Process (Expansion to entire database)
PPT Slide
Proven Technology Platform
Dominant Position in Oral Delivery
PPT Slide
PPT Slide
PPT Slide
PPT Slide
Heparins/Anticoagulants: Size and Potential
Heparin Family of Product Candidates
Oral Heparin
The PROTECT© Trial
The PROTECT© Trial
Oral Heparin Solution Program Status
Asthma and Allergy Markets
PPT Slide
PPT Slide
The Ideal Delivery Option
Oral Delivery: Function Follows the Anatomy
Key Role of the Liver
Current Delivery Options
Emisphere’s Oral Delivery Solution
PPT Slide
Blood Glucose and Insulin Levels
Subcutaneous vs. Oral Insulin Dosing
Calendar Year 2001
Strong Financial Position
Current Investment Considerations
PPT Slide
|